Psi Advisors, LLC Amgen Inc Transaction History

Psi Advisors, LLC

$338 Million
Q3 2024

A detailed history of Psi Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Psi Advisors, LLC holds 402 shares of AMGN stock, worth $118,401. This represents 0.04% of its overall portfolio holdings.

Number of Shares

402

Previous 401 0.25%

Holding current value

$118,401

Previous $125,000 3.2%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $309 - $337	1 Added 0.25%	402 $129,000
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $4,204 - $5,108	16 Added 4.16%	401 $125,000
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $268 - $324	1 Added 0.26%	385 $109,000
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $45,770 - $51,634	-179 Reduced 31.79%	384 $110,000
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $218 - $271	1 Added 0.18%	563 $151,000
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $79,494 - $94,000	371 Added 194.24%	562 $124,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $225 - $275	1 Added 0.53%	191 $46,000
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $33,896 - $43,069	-148 Reduced 43.79%	190 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $59,257 - $66,831	-264 Reduced 43.85%	338 $76,000
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $84,670 - $94,223	-367 Reduced 37.87%	602 $147,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $994 - $1,138	5 Added 0.52%	969 $218,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $204,628 - $239,746	964 New	964 $205,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $78,727 - $104,414	-432 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $81,738 - $105,062	432 New	432 $104,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.

Account